Although data from early phase trials suggest that retatrutide is well tolerated with a similar adverse event profile to GLP-1 RAs, additional research assessing long-term safety and efficacy of retatrutide in people living with obesity and/or T2D (including cardiovascular outcomes) is awaited over the next five years
Overall, both classes are indifferently recommended by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) as first-line therapy in patients with T2DM and established ASCVD or multiple ASCVD risk factors to reduce the risk of major adverse cardiovascular events (MACE), such as myocardial infarction, stroke, and cardiovascular death [6, 7]
Fortunately, recent scientific studies have illuminated natural strategies to help attenuate the progression of glaucoma
Safety, Dosage, and Long-Term Use Safety and Efficacy in Humans Although ipamorelin has been shown to be relatively safe in clinical studies with minimal side effects compared to other GH secretagogues, much of the research into ipamorelin is still in early stages
AMPK acts as an energy sensor and reduces the synthesis of nitrogen metabolism-related enzymes by inhibiting mTORC1 activity in a low-energy state, while promoting autophagy to recycle nitrogen sources(Gonzlez et al